Ariad Pharma (ARIA) Misses Q1 Loss Views by 3c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $25.09 -1.72%
Financial Fact:
Net income (loss): -27.83M
Today's EPS Names:
PODC, CLIR, ARDS, More
Financial Fact:
Net income (loss): -27.83M
Today's EPS Names:
PODC, CLIR, ARDS, More
Join SI Premium – FREE
Ariad Pharma (NASDAQ: ARIA) reported Q1 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $81 thousand versus the consensus estimate of $300 thousand.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
For earnings history and earnings-related data on Ariad Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
- Jack Henry (JKHY) Tops Q4 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
